A detailed history of Lindenwold Advisors transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Lindenwold Advisors holds 3,340 shares of LMAT stock, worth $339,711. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,340
Previous 3,340 -0.0%
Holding current value
$339,711
Previous $221,000 23.98%
% of portfolio
0.15%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$54.0 - $71.06 $180,360 - $237,340
3,340 New
3,340 $221,000
Q2 2023

Aug 07, 2023

BUY
$50.38 - $68.21 $164,742 - $223,046
3,270 New
3,270 $220,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.23B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Lindenwold Advisors Portfolio

Follow Lindenwold Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindenwold Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Lindenwold Advisors with notifications on news.